ClinConnect ClinConnect Logo
Search / Trial NCT05935397

HanYang University Medical Center (HYUMC) Registry

Launched by HANYANG UNIVERSITY SEOUL HOSPITAL · Jun 29, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The HanYang University Medical Center (HYUMC) Registry is a study that looks at patients with coronary artery disease (CAD) who have undergone a procedure called percutaneous coronary intervention (PCI). This procedure is often used to open blocked arteries in the heart using a special type of stent. The goal of the registry is to understand how these patients do over the long term after their treatment and to find out what factors might lead to complications or problems later on.

To join the study, patients must have had PCI with a drug-eluting stent at one of the participating Hanyang University hospitals since 2012. Unfortunately, not everyone can participate; for example, patients who have been hospitalized multiple times or who passed away during their initial treatment cannot enroll. Participants will be monitored over time to collect important health information, helping researchers learn more about the best ways to care for patients with heart issues in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang University Guri Hospital, Korea.
  • Exclusion Criteria:
  • second or subsequent hospitalization records of patients with multiple admissions
  • patients who died during index hospitalization
  • patients who treated with first-generation drug eluting stent
  • patients with an outpatient follow-up record of less than 6 months
  • patients with insufficient medical records.

About Hanyang University Seoul Hospital

Hanyang University Seoul Hospital is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to conduct cutting-edge studies that aim to enhance patient outcomes and contribute to the broader medical community. With a focus on ethical research practices and patient safety, Hanyang University Seoul Hospital collaborates with various stakeholders to explore new therapeutic interventions across diverse medical fields, fostering a culture of scientific inquiry and discovery.

Locations

Seoul, , Korea, Republic Of

Guri, , Korea, Republic Of

Seoul, , Korea, Republic Of

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported